Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Dermatologic 1Classical hematology 1

Conditions

Uterine Cervical Neoplasms 2Uterine Cervical Dysplasia 2Mouth Neoplasms 2Tobacco Use Disorder 1Precancerous Conditions 1Neoplasms 1Lichen Planus 1Leukokeratosis, Hereditary Mucosal 1Fanconi Anemia 1Erythroplasia 1Breast Neoplasms 1

Interventions

fludarabine phosphate 6Cyclophosphamide 6Antilymphocyte Serum 6Busulfan 5Radiotherapy 3Peripheral Blood Stem Cell Transplantation 3Methylprednisolone 3Melphalan 3Filgrastim 3Cord Blood Stem Cell Transplantation 3thymoglobulin 2fludarabine 2SRA737 2Mycophenolic Acid 2Granulocyte Colony-Stimulating Factor 2AP 1903 reagent 2sargramostim 1prexasertib 1Whole-Body Irradiation 1Tacrolimus 1Stem Cell Transplantation 1Spectrometry, Fluorescence 1Quercetin 1Optical Imaging 1Molecular Diagnostic Techniques 1Gemcitabine 1Ethanol 1Dietary Supplements 1Cyclosporine 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Fanconi Anemia × Spectrometry, Fluorescence × Clear all
NCT00542373 2026-03-05

Widefield Fluorescence and Reflectance Imaging Systems and Oral Tissue Samples in Monitoring Participants at Risk for Developing Oral Cancer

M.D. Anderson Cancer Center

Phase NA Active not recruiting
338 enrolled
Classical hematologyDermatologicHead & Neck

Erythroplasia, Fanconi Anemia, Lichen Planus, Mouth Neoplasms, Tobacco Use Disorder, Leukokeratosis, Hereditary Mucosal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡